A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes

被引:0
|
作者
Hong-Xiang Liu
Luca Cartegni
Michael Q. Zhang
Adrian R. Krainer
机构
[1] Cold Spring Harbor Laboratory,
[2] Xencor Inc.,undefined
来源
Nature Genetics | 2001年 / 27卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Point mutations can generate defective and sometimes harmful proteins. The nonsense-mediated mRNA decay (NMD) pathway minimizes the potential damage caused by nonsense mutations1,2,3,4. In-frame nonsense codons located at a minimum distance upstream of the last exon-exon junction are recognized as premature termination codons (PTCs), targeting the mRNA for degradation. Some nonsense mutations cause skipping of one or more exons, presumably during pre-mRNA splicing in the nucleus; this phenomenon is termed nonsense-mediated altered splicing (NAS), and its underlying mechanism is unclear1,2,5,6. By analyzing NAS in BRCA1, we show here that inappropriate exon skipping can be reproduced in vitro, and results from disruption of a splicing enhancer in the coding sequence. Enhancers can be disrupted by single nonsense, missense and translationally silent point mutations, without recognition of an open reading frame as such. These results argue against a nuclear reading-frame scanning mechanism for NAS. Coding-region single-nucleotide polymorphisms7 (cSNPs) within exonic splicing enhancers or silencers may affect the patterns or efficiency of mRNA splicing, which may in turn cause phenotypic variability and variable penetrance of mutations elsewhere in a gene.
引用
收藏
页码:55 / 58
页数:3
相关论文
共 50 条
  • [41] Consequences of BRCA1 missense mutations in the RING domain may be revealed by the solution structure of the BRCA1/BARD1 complex.
    Brzovic, PS
    Welcsh, PL
    King, MC
    Klevit, RE
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 205 - 205
  • [42] Detection of exon skipping events in BRCA1 RNA using MLPA kit P002
    Rita D. Brandão
    Demis Tserpelis
    Encarna Gómez García
    Marinus J. Blok
    Molecular Biology Reports, 2012, 39 : 7429 - 7433
  • [43] Detection of exon skipping events in BRCA1 RNA using MLPA kit P002
    Brandao, Rita D.
    Tserpelis, Demis
    Garcia, Encarna Gomez
    Blok, Marinus J.
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (07) : 7429 - 7433
  • [45] High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer
    T. Yu. Smirnova
    N. I. Pospekhova
    L. N. Lyubchenko
    S. A. Tjulandin
    R. F. Gar’kavtseva
    E. K. Ginter
    A. V. Karpukhin
    Bulletin of Experimental Biology and Medicine, 2007, 144 : 83 - 85
  • [46] Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer
    D Steinmann
    M Bremer
    D Rades
    B Skawran
    C Siebrands
    J H Karstens
    T Dörk
    British Journal of Cancer, 2001, 85 : 850 - 858
  • [47] Mutations of the BRCA1 and BRCA2 genes in German breast cancer patients
    Skawran, B
    Bremer, M
    Stuhrmann, M
    Volkmann, C
    Schmidtke, J
    Karstens, JH
    Dörk, T
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 120 - 120
  • [48] BRCA1 mutations and phenotype
    Grade, K
    Hoffken, K
    Kath, R
    Nothnagel, A
    Bender, E
    Scherneck, S
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1997, 123 (01) : 69 - 70
  • [49] High incidence of mutations in BRCA1 and BRCA2 genes in ovarian cancer
    Smirnova, T. Yu.
    Pospekhova, N. I.
    Lyubchenko, L. N.
    Tjulandin, S. A.
    Gar'kavtseva, R. F.
    Ginter, E. K.
    Karpukhin, A. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 144 (01) : 83 - 85
  • [50] Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer
    Steinmann, D
    Bremer, M
    Rades, D
    Skawran, B
    Siebrands, C
    Karstens, JH
    Dörk, T
    BRITISH JOURNAL OF CANCER, 2001, 85 (06) : 850 - 858